Environmental Engineering Reference
In-Depth Information
30. Bindila L, Froesch M, Lion N et al (2004) A thin chip microsprayer system coupled to Fourier
transform ion cyclotron resonance mass spectrometry for glycopeptide screening. Rapid
Commun Mass Spectrom 18(23):2913-2920
31. Lion N, Reymond F, Girault HH, Rossier JS (2004) Why the move to microfluidics for protein
analysis? Curr Opin Biotechnol 15(1):31-37
32. Feng X, Liu BF, Li J, Liu X (2014) Advances in coupling microfluidic chips to mass
spectrometry. Mass Spectrom Rev. doi:
10.1002/mas.21417
[Epub ahead of print]
33. Cortes DF, Kabulski JL, Lazar AC, Lazar IM (2011) Recent advances in the MS analysis of
glycoproteins: capillary and microfluidic workflows. Electrophoresis 32(1):14-29
34. Zamfir AD, Bindila L, Lion N et al (2005) Chip electrospray mass spectrometry for carbohy-
drate analysis. Electrophoresis 26(19):3650-3673
35. de Duve C (1959) Lysosomes, a new group of cytoplasmic particles. Subcellular particles.
Ronald Press, New York
36. de Duve C (1975) Exploring cells with a centrifuge. Science 189(4198):186-194
37. de Duve C (1964) From cytases to lysosomes. Fed Proc 23:1045-1049
38. de Duve C (1983) Lysosomes revisited. Eur J Biochem 137:391-397
39. Walkley SU, Vanier MT (2009) Secondary lipid accumulation in lysosomal disease. Biochim
Biophys Acta 1793(4):726-736
40. Lamanna WC, Lawrence R, Sarrazin S, Esko JD (2011) Secondary storage of dermatan sulfate
in Sanfilippo disease. J Biol Chem 286(9):6955-6962
41. Winchester B (2004) Lysosomal disorders of the brain. Oxford University Press, Oxford
42. Saftig P, Klumperman J (2009) Lysosome biogenesis and lysosomal membrane proteins:
trafficking meets function. Nat Rev Mol Cell Biol 10(9):623-635
43. Platt FM, Boland B, van der Spoel AC (2012) Lysosomal storage disorders: the cellular impact
of lysosomal dysfunction. J Cell Biol 199(5):723-734
44. Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage
disorders. JAMA 281(3):249-254
45. Pinto R, Caseiro C, Lemos M et al (2004) Prevalence of lysosomal storage diseases in
Portugal. Eur J Hum Genet 12(2):87-92
46. Meikle, P. J, Fuller, M, Hopwood, J. J. Mass spectrometry in the study of lysosomal storage
disorders. Cell. Mol. Biol. (Noisy-le-grand), 49(5), 769-77, 2003.
47. Meikle PJ, Ranieri E, Meikle PJ, Simonsen H et al (2004) Newborn screening for lysosomal
storage disorders: clinical evaluation of a two-tier strategy. Pediatrics 114(4):909-916
48. Nielsen TC, Rozek T, Hopwood JJ, Fuller M (2010) Determination of urinary oligosaccharides
by high-performance liquid chromatography/electrospray ionization-tandem mass spectrom-
etry: application to Hunter syndrome. Anal Biochem 402(2):113-120
49. Wenger DA, Coppola S, Liu SL (2002) Lysosomal storage disorders: diagnostic dilemmas and
prospects for therapy. Genet Med 4(6):412-419
50. Wynn R (2011) Stem cell transplantation in inherited metabolic disorders. American Society
of Hematology, ASH Education Book, Washington, DC
51. Cox TM (2005) Substrate reduction therapy for lysosomal storage diseases. Acta Paediatr
Suppl 94(447):69-75
52. Sands MS, Davidson BL (2006) Gene therapy for lysosomal Storage diseases. Mol Ther 13
(5):839-849
53. Seregin SS, Amalfitano A (2011) Gene therapy for lysosomal storage diseases: progress,
challenges and future prospects. Curr Pharm Des 17(24):2558-2574
54. la Marca G, Casetta B, Malvagia S et al (2009) New strategy for the screening of lysosomal
storage disorders: the use of the online trapping-and-cleanup liquid chromatography/mass
spectrometry. Anal Chem 81(15):6113-6121
55. Kasper DC, Herman J, De Jesus VR et al (2010) The application of multiplexed, multi-
dimensional ultra-high-performance liquid chromatography/tandem mass spectrometry to
the high-throughput screening of lysosomal storage disorders in newborn dried bloodspots.
Rapid Commun Mass Spectrom 24(7):986-994
